83
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Impact of the COVID-19 Pandemic on the Management of Acute Myocardial Infarction

, , &
Pages 3119-3124 | Published online: 02 Jul 2021

References

  • Yang C, Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic-COVID-19 and cardiovascular diseases. JAMA Cardiol. 2020;5(7):743. doi:10.1001/jamacardio.2020.0934
  • Li L, Hill J, Spratt JC, Jin Z. Myocardial injury in severe COVID-19: identification and management. Resuscitation. 2021;160:16–17. PMID: 33450334; PMCID: PMC7836289. doi:10.1016/j.resuscitation.2020.11.040
  • Li Z, Guan X, Mao N, et al. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021;8:100094. PMID: 33585828; PMCID: PMC7864613. doi:10.1016/j.lanwpc.2021.100094
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239. doi:10.1001/jama.2020.2648
  • Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75(22):2871–2872. doi:10.1016/j.jacc.2020.04.011
  • Tam CF, Cheung KS, Lam S, et al. Impact of Coronavirus Disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e6631. doi:10.1161/CIRCOUTCOMES.120.006631
  • Hammad TA, Parikh M, Tashtish N, et al. Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter. Catheter Cardiovasc Interv. 2020. doi:10.1002/ccd.28997
  • Xiang D, Xiang X, Zhang W, et al. Management and outcomes of patients with STEMI during the COVID-19 pandemic in China. J Am Coll Cardiol. 2020;76(11):1318–1324. PMID: 32828614; PMCID: PMC7438071. doi:10.1016/j.jacc.2020.06.039
  • Cao X, Spratt JC, Jin Z. Coronavirus disease 2019 (COVID-19) and acute cardiovascular disease management: a Chinese perspective on striking the balance. Resuscitation. 2020;152:36–38. doi:10.1016/j.resuscitation.2020.05.010
  • De Rosa S, Spaccarotella C, Basso C, et al.; Società Italiana di Cardiologia and the CCU Academy investigators group. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083–2088. Erratum in: Eur Heart J. 2021 Feb 11;42(6):683. Erratum in: Eur Heart J. 2021 Jan 21;42(4):322. PMID: 32412631; PMCID: PMC7239145. doi:10.1093/eurheartj/ehaa409
  • Cosentino N, Bartorelli AL, Marenzi G. Time to treatment still matters in ST-elevation myocardial infarction: a call to maintain treatment effectiveness during the COVID-19 pandemic. Eur Heart J Cardiovasc Pharmacother. 2020;6(6):408–409. PMID: 32428204; PMCID: PMC7314092. doi:10.1093/ehjcvp/pvaa054
  • Cosentino N, Assanelli E, Merlino L, Mazza M, Bartorelli AL, Marenzi G. An in-hospital pathway for acute coronary syndrome patients during the COVID-19 outbreak: initial experience under real-world suboptimal conditions. Can J Cardiol. 2020;36(6):961–964. PMID: 32376346; PMCID: PMC7162765. doi:10.1016/j.cjca.2020.04.011